Monarch Partners Asset Management LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 96 filers reported holding RECRO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Monarch Partners Asset Management LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2020$298,000
-44.2%
65,3970.0%0.07%
-61.0%
Q1 2020$534,000
-43.8%
65,397
+26.2%
0.19%
-11.8%
Q4 2019$950,000
-2.8%
51,802
-41.2%
0.21%
+44.2%
Q3 2019$977,000
+23.7%
88,137
+13.5%
0.15%
+30.1%
Q2 2019$790,000
+104.7%
77,687
+17.9%
0.11%
+94.8%
Q1 2019$386,000
-2.8%
65,917
+18.0%
0.06%
+1.8%
Q4 2018$397,000
+57.5%
55,857
+57.4%
0.06%
+147.8%
Q3 2018$252,000
+41.6%
35,4900.0%0.02%
+43.8%
Q2 2018$178,00035,4900.02%
Other shareholders
RECRO PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders